As Managing Director and Executive Creative Director at Neon, an FCB Health Network company, Kevin has led the agency over the past 7+ years into continued double-digit growth year after year, expanding the agency client roster and resulting in a unique, full-service offering. Kevin is directly responsible for maintaining the stability and growth of the company and for producing exceptional creative work, and he is always driven to exceed expectations.
With over 25 years in healthcare advertising at numerous top agencies, he has spent his career across countless disease categories with clients like AbbVie, Genentech, Janssen, Novartis and Pfizer, as well as smaller, burgeoning biopharmaceutical companies. His work has seen dozens of launches of brands, including blockbusters in the mainstream, like Invokana, Cosentyx, Bextra, Protonix and Prevnar 13, as well as those in rare disease categories and virtually everything in between.
Kevin’s work has been honored in MM&M, Med Ad News, The CLIOs, The Global Awards, shortlisted at Cannes, and recognized by many others, including the distinction of having Neon be named as a finalist in 2017 as Mid-Size Agency of the Year.